At a glance
- Originator GEA Farmaceutisk Fabrik AS
- Developer GEA Farmaceutisk Fabrik AS; Novartis
- Class Antiasthmatics; Anticoagulants; Antihypertensives; Small molecules; Triazoles
- Mechanism of Action Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Intraoperative hypertension; Pulmonary hypertension
Most Recent Events
- 05 Dec 2003 No development reported - Preclinical for Pulmonary hypertension in Scandinavia (unspecified route)
- 22 Mar 2000 No-Development-Reported for Airway obstruction in Scandinavia (Unknown route)
- 22 Mar 2000 No-Development-Reported for Intraoperative hypertension in Denmark (Unknown route)